Skip to main content
Clinical Trials/JPRN-UMIN000003438
JPRN-UMIN000003438
Completed
未知

Cinacalcet and concurrent intravenous calcitriol for treatment of secondary hyperparathyroidism in dialysis patients compared with intravenous calcitriol alone - Comparison of cinacalcet and concurrent intravenous calcitriol with calcitriol alone

1.Division of Internal medicine, Seseragi hospital 2.Department of Medicine & Biological Science Gunma University Graduate School of Medicine0 sites100 target enrollmentApril 3, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
secondary hyperparathyroidism
Sponsor
1.Division of Internal medicine, Seseragi hospital 2.Department of Medicine & Biological Science Gunma University Graduate School of Medicine
Enrollment
100
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 3, 2010
End Date
February 1, 2012
Last Updated
2 years ago
Study Type
Interventional,observational
Sex
All

Investigators

Sponsor
1.Division of Internal medicine, Seseragi hospital 2.Department of Medicine & Biological Science Gunma University Graduate School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.severe liver dysfunction or cirrhosis 2\.parathyroidectomy within the previous 24 weeks 3\.patients receiving or likely to use within 52 weeks of corticosteroid except for external use 4\.use of bisphosphonate 5\.pregnant or nursing 6\.unsuitable patients

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Cinacalcet for the treatment of hypercalcemia with persistent hyperparathyroidism in renal transplant recipients: a case siries study.Hypercalcemia with persistent hyperparathyroidism in renal transplant recipients.
JPRN-UMIN000003236St Marianna University15
Completed
Phase 4
Efficacy and safety of treatment with Cinacalcet in patients with Primary Hyperparathyroidism due to a MEN-1 mutatiohyperactive parathyroid glandsprimary hyperparathyroidism1008362410033949
NL-OMON34871eids Universitair Medisch Centrum20
Completed
Not Applicable
A combination of cinacalcet with maxacalcitol for regression of moderate to advanced secondary hyperparathyroidism in patients on chronic hemodialysissecondary hyperparathyroidism
JPRN-UMIN000001478Kitano Hospital Division of Nephrology and Dialysis50
Recruiting
Not Applicable
Effects of etelcalcetide and cinacalcet for the vascular carcification in hemodialysis patients with secondary hyperparathyroidismHemodialysis patients complicated with secondary hyperparathyroidism
JPRN-UMIN000027454Matsunami general hospital30
Active, not recruiting
Not Applicable
Efficacy and safety of the calcimimetic Cinacalcet in the management of patients with Primary Hyperparathyroidism due to a MEN-1 mutation - Cinacalcet in MEN-I PHPTPatients with primary hyperparathyroidism due to a germline mutation in the MEN-1 geneMedDRA version: 12.1Level: LLTClassification code 10036693Term: Primary hyperparathyroidism
EUCTR2010-018861-53-NLeiden University Medical Center